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Surgical Approaches for Primary and Metastatic 
Liver Neoplasms, Including Total Hepatectomy 
with Orthotopic Liver Transplantation 
,oq 
THOMAS E. STARZL, M.D., PH.D., AND 
LAWRENCE 1. KOEP, M.D. 
Dudhg the last 15 years, very important formed extended right hepatic lobectomy 
advances have been made in two areas of (trisegmentectomy) for a patient with such 
hepatic surgery. First, techniques have extensive disease. Histopathologically, the 
been perfected that permit the relatively nodules, which have a cobblestone appear-
safe removal of as much as 85 to 90 percent ance, are composed of uniformly normal-ap-
of the liver. 1 Second, it has become feasible pearing liver cells in cords or sheets, usually 
to carry out total removal of a diseased liver without orientation to central veins or portal 
and to replace it with a hepatic homograft. 2 triads which are sparse. There may be areas 
This chapter will consider the limitations of fibrosis, infarction, or hemorrhage . 
and possible benefits of these approaches in Among solid hepatic neoplasms, one 
the field of oncology. - tumor has a special place by virtue of its oc-' 
DIAGNOSTIC PITFALLS 
casional huge size, slow natural history, and 
failure to metastasize. These characteris-
tics, which were particularly well recog-
In the absence of contraindications such nized by Edmondson," have caused this 
tumor to be called benign hepatoma, mini-
as proven metastases, abdominal explora-
tion should usually be carried out without 
delay to obtain a tissue diagnosis and with a 
view to curative resection, if feasible. From 
the biopsy tissue, the accurate and rapid 
histopath~logic classification of liver masses 
is essential. A potentially serious error is 
failure to recognize for what it is a lesion 
known as focal nodular hyperplasia. These 
masses, which are not true neoplasms, do 
not ordinarily require major resection and 
should usually be left alone except for bi-
opsy. There are exceptions to this general-
ization, since rupture and massive bleeding 
have been reported,3 particularly with large 
areas of involvement that may, in addition, 
cause pressure symptoms. We have per-
This work was supponed by research grants MRIS 
8818-01 and 7227-01 from the Veterans Administration; 
by grants AM-17260 and AM-07772 from the National 
Institutes of Health; and by grants RR-00051 and RR-
00069 from the General Clinical Research Centers Pro-
gram of the Division of Research Resources, National 
Institutes of Health. 
mum deviation hepatoma, or hepatic ade-
noma. Another designation has been "pill 
tumor" because of the frequent association 
of these neoplasms in young women with the 
use of oral contraceptive drugs. Alpha-feto-
protein determinations are negative (see 
chapter by Drs. Christopherson and Mays. 
The tendency of hepatic adenomas to rup-
ture has made their presence similar to that 
of a time bomb. Two women with hepatic 
adenomas treated early in our experience 
presented with massive bleeding. After 
emergency hepatic lobectomy, the women 
carried the diagnosis of hepatoma and were 
treated with 5-fiuorouracil for more than 2 
years before the pathologic specimens were 
reviewed and reclassified. Of the 7 women 
with hepatic adenomas treated by us, all are 
well with follow-ups of from 1 to almost 8 
years after hepatic resection . 
Hepatic cell carcinoma (hepatoma) ac-
counts for 80 to 90 percent of the malignant 
primary hepatic neoplasms. Cholangiocar-
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cinoma is next in frequency. Both tumors 
may be multifocal. The list of unusual or 
rare malignancies is a long one, including 
hemangioendothelial sarcoma, squamous 
cell carcinoma in an intrahepatic cyst, and 
carcinoma of the larger intrahepatic ducts. 
Patients with the last type of neQplasm may 
be candidates for liver transplantation (see 
below). 
PARTIAL HEPATECTOMY 
The Limits of Safe Removal 
The human liver consists of four seg-
ments. The segmental combinations that 
lend themselves to excision (Fig. 1) include 
the right and left true lobes (each consisting 
of two segments), the true right lobe plus the 
medial segment of the left lobe (trisegmen-
tectomy or extended right lobectomy), and 
the lateral segment of the left lobe. In plan-
ning the appropriate operation, the dissec-
tion may be facilitated by information from 
preoperative arteriography (Fig. 2). Conse-
Trisegmentectomy 
! 
Right lobectomy 
I 
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quently, this study is performed in many 
candidates for partial hepatectomy. 
The historically high risk of hepatic resec-
tion has been reduced drastically. Since 
1963, more than 35 patients have been 
operated upon by the senior author (T.E.S.) 
at the University of Colorado (Table 1), and 
no patient has died after partial hepatec-
tomy. The numbers of hepatic resections 
have increased steadily, so that the majority 
of these partial hepatectomies have been 
since 1970. Twenty of the 37 patients have 
had trisegmentectomy, and the rest had re-
moval of conventional lobes or of the lateral 
segment (Table 1) • 
Operative Evaluation 
At exploration, if the lesion in question is 
thought to be other than focal nodular hy-
perplasia and if it is resectabl"e and localized 
to the liver, enough liver is removed by one 
of the formal resections shown in Fig. 1 to 
excise the mass with as full a margin as pos-
sible. We believe that the piecemeal re-
Falciform 
lig. 
+ 
I 
Lateral segmentectomy 
i 
Left lobectomy 
Fig. I. The common hepatic resections, of which there are only four. The most radical procedure, 
trisegmentectomy, involves removal of the true right lobe plus the medial segment of the left lobe. The 
least radical procedure, lateral segmentectomy, was incorrectly termed left lobectomy in the older liter-
ature. 
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Fig.2. Arteriogram performed prior to trisegmentectomy for hepatic adenoma in a 16-year-old girl. 
The entire liver was supplied by an anomalous artery (A) arising from the superior mesenteric artery 
(SMA). Branches to the right lobe and to the medial segment of the left lobe were ligated (large arrows), 
preserving the main trunk and its tiny branch to the left lateral segment (small arrow). 
moval of hepatic masses, even those 
thought to be benign, is rarely justifiable 
from a technical point of view if the amount 
of excised tissue is to be more than 100 or 
200 gm. 
The assessment of operability varies from 
case to case. Two criteria must be fulfilled. 
First, the operator must be sure that the 
liver fraction left behind has an intact blood 
supply and adequate biliary drainage. Sec-
ond, it must be determined that tumor 
spread has not already made the operation 
futile. 
The Special Question of Liver 
Metastases 
The expectations after resection for he-
patic metastases are unclear. With the ex-
ception of carcinoid tumors, there is sur-
prisingly little actual experience with partial 
hepatectomy for metastatic disease. Flana-
gan and Foster in 1%7 surveyed the world 
literature and found 32 reports involving 72 
patients who had survived liver resection. 
The primary malignancy was colonic in 45 
instances. The overall 5-year survival rate 
for the 72 patients was 24 percent. 
Later, Foster, and Berman,6 in a liver 
tumor survey of 98 U.S. hospitals, made a 
critical review of surgical resections for 
metastatic cancer to the liver. They found 
that 176 patients had undergone surgical re-
section for embolic metastases to the liver of 
which 126 patients (72%) had primaries in 
the colon or rectum. Eight of 126 patients 
with liver resection for metastatic colon and 
rectal cancer died immediately after the op-
eration. Follow-up data were not available in 
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TABLE 1 
Hepatic Reseetions O%3-July 1977)* 
Trisegmentectomy 
Right lobectomy 
Left lobectomy 
Lateral segmentectomy 
Total 
Number 
20 
8 
5 
4 
37 
Late Deathst 
6 
o 
3 
1 
10 
• Thirteen of these resections were for benign disease 
(7 hepatic adenomas, 2 focal nodular hyperplasia, 2 
traumatic injuries, 1 hemangioma, and 1 single simple 
cyst). The other 24 patients had primary or metastatic 
liver disease. 
t All 10 patients had recurrent tumor, which in 9 
cases was directly responsible for death after 41 months 
to 5 years. One patient with recurrence died of hepatic 
insufficiency 2 months after trisegmentectomy. 
5 of the remaining U8 patients, and 25 pa-
tients were followed for less than 5 years. Of 
the 88 patients available for the 5-year eval-
uation, 16 patients (18 percent) were alive 60 
months after liver resection. Six of these pa-
STARZL AND KOEP 
tients developed recurrences, and 4 of the 6 
had died. Thus, 10 of the 88 determinate 
cases seem "cured." 
Since the lure of describing successes ex-
ceeds the temptation to report failures, the 
reported series may be an overstatement of 
the therapeutic expectations. Yet the report 
by Wilson and Adson7 from the Mayo Clinic 
of 60 hepatic resections for metastatic colon 
disease was also optimistic. When resection 
was performed for multiple metastases, 
. there were no S-year survivors. But when 
the metastases were single, 42 percent of 36 
patients lived for 5 years or more and 8 were 
alive without recurrence 10 years or more 
after hepatectomy. 
In the last 13 years, we have performed 
hepatectomy fot metastatic cancer upon 
only 9 patients (Table 2); 3 had primary 
colon or rectal carcinoma, and 1 each had 
carcinoid, Wilm's tumor, carcinoma of gall-
bladder, neuroblastoma, glucagonoma, and 
TABLE 2 
Liver Resections for Metastatic Tumor at University of Colorado· 
Date of Operation; 
Patient Type of Follow-up Survival 
Number Age Hepatectomy Primary Tumor (to September 19, 1977) (Months) 
2 1218174 Neuroblastoma, _ . No evidence of tumor 33 
Trisegmentectomy right adrenal 
2 71 7/12176 CA colon No evidence of tumor 33 
Left lateral 
segmentectomy 
3 43 2112/75 CA colon Died 8/12/76; metastases to 18 
Trisegmentectomy brain and lung 
4 41 4/29175 CA gallbladder Died 10/&'76; widespread 14 
Trisegmentectomy metastases 
5 12 5130175 Wilm's tumor of Died 3/17176; Wilm's 91 
Left lobectomy kidney tumor, left flank 
6 48 10127175 CA rectum Positive CEA but no 23t 
Trisegmentectomy demonstrable tumor 
7 50 4129176 Glucagonoma of Died 5/15177; widespread 
.... 
13 
Trisegmentectomy ? pancreas metastases 
8 50 7112/76 Metastatic carcinoid Small tumor nodules in 14 
Left lateral of ileum remnant, not obviously 
segmentectomy changed 
9 34 7n&'77 Melanoma of eye Small residual tumor 2 
Right lobectomy nodules left in remnant 
* Except in case I, the primary tumors were resected from 1 month to 14 years earlier. The 14-year 
interval was in patient 9. 
t Right lower lobectomy for metastatic tumor of lung on 6/1/76. 
..... 
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melanoma. The results with these cases 
have been encouraging, although the follow-
ups are still relatively short. Five of the 9 pa-
tients are still alive, and 2 are free of tumor 
as far as can be determined. 
The paucity of our experience and that 
elsewhere undoubtedly reflects the ten-
dency of liver metastases to be widespread 
once they occur. However, a further factor 
could be a bias against using secondary par-
tial hepatectomy because of its reputed high 
mortality. The reduction in operative risk in 
recent times should encourage an aggres-
sive approach. 
Postoperative Therapy 
The tacit assumption is usually made that 
neither irradiation nor chemotherapy is safe 
or effective following subtotal hepatectomy, 
but such negative attitudes may eventually 
prove to be completely unjustifiable. p~v­
eral of our recent patients with hepatomas 
have been treated with the triple drug regi-
men of cyclophosphamide, 5-fiuorouracil, 
and vincristine sulfate with or without adria-
mycin. Therapy was not started for several 
weeks after operation until regeneration had 
a chance to begin and good wound healing 
was evident. A number of these patients 
who had massive tumors, including some 
with blood vessel invasion, are clinically 
free of tumor after several years. 
TOTAL HEPATECTOMY 
AND TRANSPLANTATION 
The appeal of liver replacement for the 
treatment of hepatic cancers is that the 
boundaries of permissible resection could 
be considerablr expanded. Some liver 
tumors that cannot be completely excised 
by standard techniques of subtotal hepatec-
tomy would become removable if the whole 
organ could be extirpated. 
A Potentially Self-Defeating Aspect 
Of course, the extension by this means of 
surgical procedure would not ensure against 
metastases. Indeed, there is the possibility 
that the growth of residual tumor could ac-
tually be accelerated as a consequence of 
the immunosuppressive therapy that is nec-
essary for prevention of homograft rejec-
tion. This would be expected if the concept 
is valid that the immunologic system pro-
vides a surveillance function by which mu-
tant neoplastic cells are identified and either 
eliminated or restricted in their growth po-
tential. The individuality of such cells, 
which allows their recognition as foreign, 
has been thought to be due to tumor-specific 
antigens. 
It has been thoroughly documented2•8 that 
immunosuppression leads to a striking inci-
dence of new tumors and that it permits the 
transplantation of malignant tumors in 
humans which may become autonomous 
and, therefore, deadly even if immunosup-
pression is stopped. It has not been proven 
that metastases are enhanced by immuno-
suppressive therapy, but this strong possi-
bility has been raised from observations 
with patients treated with hepatic replace. 
ment for primary malignancies of the 
liver. 2•8 
Liver replacement with a homograft was 
first attempted in a human on March 1, 
1963.9 Between then and November 28 
1974, 92 more patients were similarly 
treated at our center. As was reviewed in 
December 1975 and published the following 
April,IO 27 of the 93 recipients achieved sur-
vival of at least 1 year after transplantation, 
with a maximum then of 6 years. Many of 
these patients had been able to return to a 
full and useful life. Sixteen were still alive in 
December 1975, with follow-ups of 13 to 71 
months. 
The following discussion will update the 
results in that original series, with further 
follow-ups of another 22 months. At the 
same time, attention will be focused upon 
the causes for the heavy mortality that had 
retarded the acceptance of liver transplan-
tation and upon means by which the record 
has been improved subsequently. 
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Case Material 
PEDIATRIC PATIENTS 
Fifty-six of the first 93 recipients were 18 
years or younger at the time of the operation 
(fable 3). Forty of these 56 pediatric recipi-
ents had biliary atresia. In the 36 youngest 
of the 40 patients with atresia, the mean age 
at the time of operation was 31.3 ± 15.7 
(S.D.) months, range 3 to 67. The 4 oldest 
children in the atresia group were 7, 11, 11, 
and 15 years. Because of their long survival, 
they were thought on clinical grounds to 
have intrahepatic biliary atresia, and this 
diagnosis was compatible with the histo-
pathologic findings of micronodular biliary 
cirrhosis in their native livers. Two of these 
latter four livers contained incidental liver 
cell carcinomas. Only one such malignancy 
was found in the diseased livers of the ot!ler 
36 patients with extrahepatic biliary atresia 
whose transplantations were carried out at a 
younger age. 
The 16 pediatric recipients with diag-
noses other than biliary atresia (fable 3) had 
a mean age of 12.9 ± 4.6 (S.D.) years, range 
1 to 18. Nine had sonie variant of chronic ag-
gressive hepatitis without HBsAg antigene-
mia. Three had hepatomas that could not be 
removed with conventional partial hepatec-
tomy. Two had Wilson's disease. There was 
STARZL AND KOEP 
one example each of congenital biliary cir-
rhosis and cirrhosis associated with alphal-
antitrypsin deficiency. 
ADULT PATIENTS 
The 37 adult patients treated during the 
same time averaged 39.0 ± 11.1 (S.D.) years, 
range 21 to 68. Their most frequent diag-
noses were primary hepatic malignancy, 
chronic aggressive hepatitis, and alcoholic 
cirrhosis (Table 4). All the patients with non-
neoplastic disease were profoundly ill before 
they were considered for transplantation. 
Five had the diagnosis of the hepatorenal 
syndrome, several were unconscious, and 
almost all were wasted from their chronic 
disease. 
Managelllent 
The operative and postoperative care of 
patients with liver transplantation has been 
described before,2.1o but some details de-
serve emphasis. Since 1968, when the con-
cept of brain death became widely accepted 
in the United States, cadavers usually have 
not been considered for liver donation un-
less there is still effective circulation and 
unless aortography can be performed to de-
lineate the hepatic arterial supply in ad-
vance. Complicated preservation devices 
TABLE 3 
Pediatric Patients 
Number of Survival Alive· Follow-up Present 
Diagnosis Examples >1 Year Now Survivors (Months) 
Congenital biliary atresia 40 11 (27.5) 7 35,48,56. 66, ~TRI 93 
Chronic aggressive hepatitis 9 3 (33) 2 35,44 
Hepatoma, liver cell carcinoma 3 2 (67) 0 
Wilson's disease 2 2 (100) 1 79 
Congenital biliary cirrhosist 1 1 (100) 0 
Alphal-antitrypsin deficiency 1 1 (100) 0 
Total 56 20 10 
Figures in parentheses indicate percentages. 
None of the 56 pediatric patients were HB,AG positive preoperatively. 
• The 10 late deaths were after 121. 13, 13i, 14, 20, 26, 28, 30.41. and 72 months. 
t Associated with congenital deafness. 
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TABLE 4 
Adult Patients 
Number 
of 
Diagnosis Examples 
Malignant tumor· 12 
Chronic aggressive hepatitis 9 
Alcoholic cirrhosis 9 
Primary biliary cirrhosis 3 
Secondary biliary cirrhosis I 
Sclerosi{l.g cholangitis with ulcerative colitis 1 
Massive hepatic necrosis due to hepatitis B virus 
Budd-Chiari syndrome 1 
Total 37 
Figures in parenthesis represent percentages. 
Survival 
> 1 Year 
2 (17) 
3 (33) 
1 (11) 
0(0) 
0(0) 
0(0) 
0(0) 
1 (100) 
7 (19) 
Alivet 
Now 
1 
0 
1 
0 
0 
0 
0 
1 
"3 
Follow-up 
Present 
Survivors 
(Months) 
36 
42 
35 
The patient with massive hepatic necrosis and 2 of the patients with chronic aggressive hepatitis 
had HBsAG positive tests preoperatively. 
* Included 7 liver cell carcinomas (3 with cirrhosis), 3 duct cell carcinomas at the confluence of the 
right and left hepatic ducts which caused complete bile obstruction, I cholangiocarcinoma, and I 
hemangioendothelial sarcoma. The patient who is still alive had a small obstructing duct cell carcinoma. 
t The 4 deaths after 1 year occurred after 13!, 19, 20!, and 25 months. 
are no longer used. Infant and child livers 
are usually perfused with 1 to 3 liters of a 
chilled electrolyte solution through the por-
tal vein just before and after organ removal. 
Longer preservation, for up to 18 hours, is 
feasible with infusion of intracellular elec-
trolyte solutions. ll 
The quality of HL-A matching has not 
seemed to bfluence the outcome, and for 
this reason the HL-A match has not been 
used as a criterion of donor selection for a 
number of years. 
Preformed anti-red cell isoaggIutinins 
that react against donor tissues and cyto-
toxins that can be detected by their lysis of 
donor lymphocytes immediately destroy 
many renal homografts that are trans-
planted in violation of such positive cross-
matches. The liver is very resistant to this 
so-called hyperacute rejection. In our first 
93 cases, three liver transplantations were 
carried out in spite of red blood group incom-
patibility, and three more were performed 
in confrontation of cytotoxic antibodies. 1o 
There were no unequivocal hyperacute 
rejections. 
Host hepatectomy is usually still per-
formed by individually dissecting the hilar' 
structures and the vena cava above and 
below the liver and then by cross-clamping 
and dividing the vessels just as the liver is 
removed. 2 In some adults, however, a safer 
waylO has been first to transect the hilar 
structures and subsequently the infrahepa-
tic inferior vena cava when all else is in 
readiness (Fig. 3); then, by pulling on 
clamps, which are placed on the hepatic 
side of these structures, the liver is dis-
sected free from below to above, ligating all 
cut tissues on the way (Fig. 3). The suprahep-
atic inferior vena cava remains intact as the 
stalk of the specimen until it is clamped just 
before the liver is removed. This variation 
in operation has been particularly useful in 
developing a reasonably long suprahepatic 
cuff of the inferior vena cava in adults. The 
vena cava or main hepatic veins may be dis-
sected free from within the cirrhotic liver in 
a bloodless field (Fig. 4B). 
In several of our first recipients who did 
not have biliary atresia, bile duct recon-
struction was with choledochocholedochos-
tomy over aT-tube stent (Fig. 4D). The 
method lost favor because of a high inci-
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Fig. 3. Technique of rectrograde removal of liver. (A) Incisions. (AA) Subcostal incision used for all 
orthotopic liver transplantations. (BB. CC. DO) Frequently used extensions from the AA incision. (B) 
Beginning retrograde removal after transection of inferior vena cava and hilar structures. All posterior 
tissue that is cut should be ligated. although the named vessels encountered. such as the right adrenal 
vein. are few in number. (By permission of Surgery Gynecology and Obstetrics 142:487-505. 1976.) 
dence of bile fistula, and cholecystoduode-
nostomy after ligation of the common duct 
(Fig. 4A) became our first choice for a num-
ber of years. Recently, the preferred 
techniques have been choledochocholedo-
chostomy (Fig. 4D) or, alternatively, chole-
cystojejunostomy with a Roux-en-Y loop 
(Fig. 4B), thus removing the homograft from 
the mainstream of the gastrointestinal tract 
" and draining it through a defunctionalized 
jejunal limb. Alternatively, Roux-en-Y cho-
ledochojejunostomy (Fig. 4C) has been used 
for recently treated patients. In a number of 
cases it has been necessary to convert from 
cholecystojejunostomy to choledochojejun-
ostomy (Figs. 4B and 4C) because of ob-
struction at the cystic duct. 12 
The first 5 patients were treated with 
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ci rrotic live r 
Fig. 3(C,D). (C) Operative field after retrograde liver mobilization, The last remaining structure, the 
suprahepatic inferior vena cava, has been clamped above the liver. (0) Technique for mobilizing a suitable 
length of suprahepatic vena cava after placement of clamp. In adults, this usually involves cutting away 
cirrhotic liver tissue over the frequently distorted and foreshortened right and left hepatic veins. (By 
permission of Surgery, Gynecology and Obstetricl 142:487-505. 1976.) 
azathioprine and prednisone. The next 88 
recipients were given triple drug immuno-
suppression, which usually consisted of 
azathioprine and prednisone to which a 2-
week to 4-month course of horse antilym-
phocyte or antithymocyte globulin was 
added. If hepatotoxicity of azathioprine was 
suspected, cyclophosphamide was substi-
tuted, since it has an immunosuppressive 
effect comparable to that of azathioprine. 
Results in Pediatric Patients 
OTHER THAN BIllARY ATRESIA 
Nine (56 percent) of the 16 patients lived 
for at least 1 year after transplantation. The 
7 others who received a total of eight grafts 
died after 1 to 188 days but from only one 
example each of acute rejection and late 
chronic rejection. The nonimmunologic fac-
tors of biliary obstruction, tumor recur-
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Roux 
limb T-tube in recipient 
common duct 
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Fig. 4. Techniques of biliary duct reconstruction used for most of the transplantation recipients. 
(A) Cholecystoduodenostomy. (B) Cholecystojejunostomy. (C) Choledochojejunostomy after removal of 
gallbladder. (D) Choledochocholedochostomy. Note that the T-tube is placed, if possible, in recipient 
common duct. (By permission of Surgery, Gynecology and Obstetrics 142:487-505, 1976.) 
renee, perloration of a colon diverticulum, 
and ischemic liver necrosis were responsi-
ble for all the other fatalities within the first 
year. The tumor recurrence led to death 143 
days postoperatively. 
Shortly after I year, 2 more patients died 
with recurrences from the hepatomas for 
which the transplantations had been per-
formed. The three other late deaths (fable 
2) were from chronic rejection or unrecog-
nized biliary obstruction. 
Four of the 16 recipients in this nonatresia 
pediatric subgroup are still alive after 3 to 
more than 6i years (fable 3). They all have 
normal or nearly normallive;function, with 
serum bilirubin concentrations ranging from 
0.5 to 1.5 mg/IOO ml. 
BILIARY ATRESIA 
The 40 recipients were given a total of 
45 livers. This group (fable 3) will not be 
discussed in this paper dealing with oncol-
ogy. It is presented in detail elsewhere. to 
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It should be recorded, however, that 6 of 
these recipients are still alive after 35 to 93 
months (Table 3). The longest survivor is a 
child whose liver contained a 2-cm incidental 
hepatoma. After operation, previously posi-
tive alpha-fetoprotein determinations be-
came negative. 
Results in Adult Patients 
Only 7 (19 percent) of the first 37 adult re-
cipients lived for as long as 1 year postoper-
atively. The results were not satisfactory 
after transplantation for any of the main in-
dications for liver transplantation (Table 4). 
Only 1 of 9 alcoholics survived for as long as 
a year. Three of 9 patients with chronic ag-
gressive hepatitis lived for this long, as well 
as 2 of 12 patients with primary hepatic 
tumors. The 2 patients in the malignant cat-
egory who lived for more than a year after 
liver replacement had been treated for the 
small intrahepatic duct cell carcinomas, de-
scribed by Klatskin,13 that obstruct the con-
fluence of the right and left hepatic ducts 
and cause early jaundice. One of these re-
cipients died of multiple recurrences in the 
new liver 25 months after transplantation. 
The second patient is well without evidence 
of recurre,1ce after 3 years. Two adult pa-
tients with nonneoplastic disease are also 
still alive after 35 and 42 m~nths (Table 4). 
Causes for Failure 
In reviewing these 93 consecutive (56 pe-
diatric and 37 adult) cases, it became obvi-
ous that rejection of the liver as judged by 
classical histopathologic criteria played a 
suprisingly small role in the heavy overall 
mortality, accounting for less than 10 per-
cent of the deaths. Technical or mechanical 
problems, especially those of biliary duct re-
construction, were a far greater cause of 
failure, as were systemic infections. For ex-
ample, 6 of the 37 adult recipients had lethal 
cerebrovascular accidents during or just 
after operation that were probably due to air 
embolism introduced from the homograft. 14 
When abnormalities of liver function devel-
oped in the postoperative period, the nearly 
automatic diagnosis of homograft rejection, 
in retrospect, proved to have been wrong in 
most instances. 
It was concluded that further develop-
ment of liver transplantation depended upon 
two kinds of progress. The first was reduc-
tion of operative and early postoperative ac-
cidents and complications by more discrimi-
nating patient selection, purely technical 
improvement, and better standardization of 
biliary duct reconstruction. The second area 
was in sharpening the criteria for the differ-
ential diagnosis of postoperative hepatic 
malfunction, including the liberal use of 
transhepatic cholangiography and needle bi-
opsy. Better decisions could then be made 
about changes in medication or about the 
need for secondary corrective surgical pro-
cedures. 
Institution of these reforms has markedly 
changed the outlook after liver replacement. 
For example, 29 liver transplantations were 
carried out from August 1976 to September 
1977. Twenty-one of these 29 recipients are 
still alive. With such improvement, the 
question of liver transplantation for malig-
nant disease inevitably will be raised again. 
Transplantation and Cancer 
In a positive sense, the most important 
conclusion that emerged from this early ex-
perience of 93 liver replacements was that 
prolonged survival repeatedly was possible. 
A total of 27 patients lived for at least a year 
following operation. Sixteen of this group 
were still alive in December 1975, after 
more than I to almost 6 years, and after an 
additional 22 months, 14 survivors remain. 
The outlook slowly improved as the 93 cases 
were compiled, although not to a satisfac-
tory state. The first 25 recipients included 
only 5 one-year survivors. The next group of 
25 contained 6, and the group after that had 
8. There were 8 one-year. survivors among 
the 18 patients beginning with number 76. 
The chronic survivors, particularly those in 
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recent times, have had remarkably stable 
liver function, and they have usually 
achieved complete social rehabilitation. 
The treatment of hepatic malignancies 
with liver replacement remains a controver-
sial issue. One of our patients is cured of a 
hepatoma after almost 8 years, but that neo-
plasm was small and was an incidental find-
ing in a liver that had biliary atresia. Among 
the first 93 recipients, 5 other patients with 
hepatomas who lived long enough for us to 
make observations developed recurrences, 
as did a sixth patient whose native liver and 
later whose liver graft were destroyed by a 
hemangioendothelial sarcoma. Two of 3 pa-
tients with intrahepatic duct cell carci-
nomas lived for more than 2 years, but un-
fortunately, 1 of these patients had massive 
and lethal recurrences that were predomi-
nantly in the homograft. The other is still 
alive without recurrence often more than 3 
years. 
Although details have varied, the overall 
message from Williams and his associates15 
has been the same, although somewhat 
more optimistically expressed. In their se-
ries of transplantations for four hepatomas, 
five duct cell carcinomas, two metastatic 
malignancies, and one cholangiocarcin~maI 
8 of the 12 patients were afflicted with re-
current neoplasm. Four of their 5 patients 
with duct cell carcinoma developed obvious 
metastases, the exception being a recipient 
who died after 3 weeks. On the other hand, 
hepatoma recurred once in 4 cases, but only 
1 of these recipients lived for as long as a 
year. That exceptional patient, who died of 
biliary obstruction after more than 5 years, 
was free of metastases at autopsy. Her origi-
nal tumor was apparently slow growing, 
however, since she had been aware of an ab-
dominal mass for more than 6 years preced-
ing transplantation. 
Recurrences after liver transplantation 
for primary hepatic malignancy have also 
been recorded by Hume16 and Fortner17 and 
their associates. It is axiomatic that the out-
come in any given case will depend on the 
STARZL AND KOEP 
extent of the neoplasm at the time of trans-
plantation. In this connection, a precaution-
ary note about what constitutes genuine 
candidacy for liver replacement may be in-
troduced on the basis of our unusually large 
experience with hepatic trisegmentectomy 
alluded to at the beginning of this chapter. 
A number of those patients (see Table 1) 
who, as it turned out, could be treated by 
conventional means had been referred to us 
for consideration of liver transplantation 
after an erroneous decision of nonresecta-
bility had been made at earlier operations. 
In spite of the foregoing reservations, we 
have not absolutely precluded liver trans-
plantation for malignant disease as the fol-
lowing recent case demonstrates. A 27-year-
old woman from Iowa was first diagnosed in 
1971 as having a sclerosing cholangiocarci-
noma after tissue evaluation by Dr. Kamal 
G. Ishak of the Armed Forces Institute of 
Pathology, Washington. The slowly growing 
tumor eventually caused complete biliary 
obstruction and extensively invaded the 
central part of the diaphragm. Liver re-
placement was performed on September 19, 
1976. In order to perform total hepatectomy, 
it was necessary to resect a large portion of 
99th hemidiaphragms in continuity with the 
liver. Multiple, small pulmonary metastases 
were found. 
The resected diaphragm was replaced 
with a plastic mesh (Marlex). Mter a very 
stormy postoperative course, the patient re-
covered completely and has normal liver 
function more than I year later. Postopera-
tively, she gained almost 80 pounds in 
weight. The hepatic specimen was subse-
quently reviewed by Dr. eu~ Edmondson 
of Los Angeles, who made the diagnosis of 
primary myxosarcoma of the liver. Drs. Paul 
Blaustein and R. H. Fennell of our own 
Pathology Department diagnosed the he-
patic and pulmonary lesions as sclerosing 
angiosarcoma. The full story in this patient 
can obviously be told only with longer fol-
low-up, but it is already clear that very sig-
nificant palliation has been achieved. 
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SUMMARY 
In recent years, partial hepatic resection 
for the treatment of liver tumors has become 
well standardized and safe, even with re-
moval of 80 to 90 percent of the liver. At the 
University of Colorado Medical Center, 37 
consecutive hepatic resections have been 
performed without an operative mortality in 
spite of the fact that 20 of the 37 extirpations 
were of 80 l.? 90 percent of the liver. The re-
sections have been for primary as well as 
metastatic malignancies. 
Total hepatectomy in association with 
transplantation increases the field of re-
sectability, but the extent to which exten-
sive hepatic tumors can be cured remains 
controversial. In our experience, and in that 
of other observers, the incidence of recur-
rence after liver replacement for tumors has 
ranged from 66 to more than 90 percent. 
Nevertheless, "cures" after liver repla~e­
ment for cancer have been recorded. 
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